ArticleScientific reports2021

Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells.

Monica Benvenuto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.